The second wave of Covid-19 exposed the weakness of the public healthcare system in India. It also exacerbated geographical disparities. Health inequalities need to be levelled up if India is to capitalise on the momentum that the sector has got from the Covid emergency. To be the provider of cutting-edge therapeutics and medicines, India will need to make a big investment push with a focus on manufacturing biotech drugs that meet the strictest standards.
from Latest Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/aCpYPBT
https://ift.tt/EqFKmJe
from Latest Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/aCpYPBT
https://ift.tt/EqFKmJe
Post a Comment